Reshma Shringarpure
Vice President, Clinical Research and Medical Affairs at Akero Therapeutics - South San Francisco, CA, US
Reshma Shringarpure's Colleagues at Akero Therapeutics
Brittany De Temple
director of clinical operations and program management
Reshma Shringarpure's Contact Details
HQ
650-487-6488
650-487-6488
Location
California,United States
California,United States
Company
Akero Therapeutics
Akero Therapeutics
Reshma Shringarpure's Company Details
Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.
Frequently Asked Questions about Reshma Shringarpure
Reshma Shringarpure currently works for Akero Therapeutics.
Reshma Shringarpure's role at Akero Therapeutics is Vice President, Clinical Research and Medical Affairs.
Reshma Shringarpure's email address is ***@akerotx.com. To view Reshma Shringarpure's full email address, please signup to ConnectPlex.
Reshma Shringarpure works in the Research industry.
Reshma Shringarpure's colleagues at Akero Therapeutics are Kitty Yale, Yasmine CPA, John CEP, William White, Whitney Withington, Brittany De Temple, Yuan Xu and others.
Reshma Shringarpure's phone number is 650-487-6488